EFFECTS OF ATORVASTATIN AND MELATONIN ON GLYCEMIC CONTROL AND LIPID PROFILE IN TYPE 2 DIABETIC PATIENTS
Background: Dyslipidemia is a modifiable cardiovascular disease risk factor that remains largely uncontrolled in patients with type 2 diabetes mellitus. Administration of melatonin may improve tissue responses to insulin and increase the efficacy of drugs which act through this pathway like Sulfonyl...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Al-Nahrain University/College of medicine
2016-03-01
|
| Col·lecció: | The Iraqi Journal of Medical Sciences |
| Matèries: | |
| Accés en línia: | https://iraqijms.com/index.php/jms/article/view/116 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|